AVROBIO to Present at the 21st Annual Needham Virtual Healthcare Conference

 AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a shared purpose to free people from a lifetime of genetic disease, today announced Geoff MacKay, president and CEO of AVROBIO, will present at the 21^st Annual Needham Virtual Healthcare Conference at 9:30 a.m. ET on Tuesday, April 12, 2022.

A live webcast of the presentation will be available on the investors section of avrobio.com. After the live webcast, the event will remain archived on the AVROBIO website for approximately 30 days.